Voyager Therapeutics Balance Sheet - Annual (NASDAQ:VYGR)

Add to My Stocks
$21.17 $0.6 (2.76%) VYGR stock closing price Jun 20, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Voyager Therapeutics balance sheet. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Voyager Therapeutics stock analysis. A company releases its balance sheet every year along with its annual results. Voyager Therapeutics balance sheet indicates an asset turnover ratio of 0.02 and debt to equity ratio of 0. Also check Voyager Therapeutics revenue and Voyager Therapeutics operating cash flow for the same period.

View latest 10 year balance sheet data to check Voyager Therapeutics financial performance.
show more
Fiscal year is Jan - Dec20172016201520142013
Cash31.53M36.64M31.3M7.03M-
Marketable Securities137.52M137.77M163.02M--
Receivables-----
Inventory-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets2.73M4.36M1.55M1.32M-
Total Current Assets
171.79M178.78M195.89M8.35M-
Property Plant & Equipment13.27M9.28M4.01M2.98M-
Accumulated Depreciation2.99M1.39M---
Net Property Plant & Equipment
10.28M7.89M3.23M2.8M-
Investment & Advances1.1M1.36M30M--
Other Non-Current Assets-----
Deferred Charges-----
Intangibles-----
Deposits & Other Assets1.3M1.52M---
Total Assets
184.47M189.56M229.45M11.49M-
Notes Payable----2.92M
Accounts Payable1.02M--1.55M-
Current Portion Long-Term Debt-----
Current Portion Capital Leases-----
Accrued Expenses11.49M6.48M3.43M--
Income Taxes Payable-----
Other Current Liabilities3.38M6.76M19.88M--
Total Current Liabilities
15.89M13.8M23.93M2.47M3.98M
Mortgages-----
Deferred Taxes/Income33.51M39.81M36.4M1.31M-
Convertible Debt-----
Long-Term Debt-----
Non-Current Capital Leases-----
Other Long-Term Liabilities1.01M----
Total Liabilities
50.42M53.64M60.38M10.34M3.98M
Minority Interest---6.3M-
Preferred Stock---21.97M-
Common Stock Net-----
Capital Surplus295.01M225.96M219.12M--
Retained Earnings-160.71M-90.01M-49.82M-20.83M-3.83M
Treasury Stock-----
Other Liabilities-0.28M-0.05M-0.25M--
Shareholders Equity134.05M135.92M169.07M1.14M-3.83M
Total Liabilities & Shareholders Equity184.47M189.56M229.45M11.49M-
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Voyager Therapeutics stock price, and Voyager Therapeutics historical stock prices show the stock price movement over time, and the Voyager Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Voyager Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for VYGR stock as of 2017 is $184.47M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. VYGR stock had total liabilities of $50.42M for the year 2017.

Voyager Therapeutics Balance Sheet - Key Ratios

Current ratio
7.13
Debt to equity ratio
0
Asset turnover ratio
0.02
Receivables turnover
0
Price to book ratio
6.16